JQ
James Quigley Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Kymera Therapeutics
KYMR
$3.11B
| $43.48 | $79 |
82%
upside
| Overweight |
3 Jun ‘25
3 months ago |
|
2
Sanofi
SNY
$115B
| $47.16 | $65 |
38%
upside
| Neutral |
21 Mar ‘25
5 months ago |
|
3
Novartis
NVS
$245B
| $126.55 | $121 |
4%
downside
| Neutral |
5 Sep ‘24
1 year ago |
|
4
Grifois
GRFS
$6.7B
| $9.85 | $10.50 |
7%
upside
| Neutral |
5 Dec ‘23
1 year ago |
|
5
Galapagos
GLPG
$2.13B
| $32.34 | $40 |
24%
upside
| Equal-Weight |
7 Aug ‘23
2 years ago |
|
6
Evotec
EVO
$1.21B
| $3.41 | $16 |
369%
upside
| Overweight |
23 Jun ‘23
2 years ago |
|
|
7
Galapagos
GLPG
$2.13B
| $32.34 | $45 |
39%
upside
| Neutral |
31 May ‘23
2 years ago |
|